RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M Turnover 25%
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
-15.11%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.82M
AUM Growth
-$1.32M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
3.1 years
Top 10 Avg Time Held
3.1 years
Top 20 Avg Time Held
3.1 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
OKUR icon
1
OnKure Therapeutics
OKUR
$91.1M
$3.83M 56.07%
253,422
– –
2021 Q2
12 quarters
SPRB icon
2
Spruce Biosciences
SPRB
$112M
$1.52M 22.27%
39,150
– –
2020 Q4
14 quarters
XLO icon
3
Xilio Therapeutics
XLO
$58.6M
$1.37M 20.01%
102,960
– –
2021 Q4
10 quarters
VAPO
4
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$112K 1.65%
52,881
– –
2020 Q4
14 quarters

Similar funds

RiverVest Venture Management's Q2 2024 Portfolio in Review

As of Q2 2024, RiverVest Venture Management held 4 positions worth $6.82M, down 16% from $8.14M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 0%. RiverVest Venture Management opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management's ten largest holdings make up 100% of its $6.82M portfolio in Q2 2024.
  • RiverVest Venture Management opened 0 new positions and closed 0 in Q2 2024.
  • RiverVest Venture Management's portfolio value fell 16% quarter-over-quarter to $6.82M.

Based on RiverVest Venture Management's 13F filing for Q2 2024, filed 24 Jul 2024.